News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,162 Results
Type
Article (88171)
Company Profile (825)
Press Release (784146)
Multimedia
Podcasts (206)
Webinars (30)
Section
Business (233345)
Career Advice (4152)
Deals (39895)
Drug Delivery (155)
Drug Development (91475)
Employer Resources (205)
FDA (18433)
Job Trends (17439)
News (398117)
Policy (39995)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (164)
Alliances (56982)
ALS (190)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (377)
Approvals (18635)
Artificial intelligence (677)
Autoimmune disease (191)
Automation (47)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (176)
Brain cancer (69)
Breast cancer (694)
Cancer (5323)
Cardiovascular disease (471)
Career advice (3578)
Career pathing (43)
CAR-T (317)
CDC (68)
Celiac Disease (2)
Cell therapy (870)
Cervical cancer (39)
Clinical research (77386)
Collaboration (1941)
Company closure (5)
Compensation (1226)
Complete response letters (79)
COVID-19 (3003)
CRISPR (107)
C-suite (962)
Cystic fibrosis (156)
Data (6660)
Decentralized trials (2)
Denatured (76)
Depression (161)
Diabetes (554)
Diagnostics (7319)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (100710)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135801)
Executive appointments (1069)
FDA (21793)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1636)
Gene editing (230)
Generative AI (71)
Gene therapy (714)
GLP-1 (1166)
Government (5482)
Grass and pollen (8)
Guidances (389)
Healthcare (20979)
HIV (76)
Huntington's disease (53)
IgA nephropathy (90)
Immunology and inflammation (310)
Immuno-oncology (75)
Indications (132)
Infectious disease (3320)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17971)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (73)
Kidney cancer (20)
Labor market (98)
Layoffs (662)
Leadership (44)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (716)
Lymphoma (396)
Machine learning (48)
Management (66)
Manufacturing (918)
MASH (182)
Medical device (15087)
Medtech (15152)
Mergers & acquisitions (23041)
Metabolic disorders (1474)
mRNA (201)
Multiple sclerosis (179)
NASH (23)
Neurodegenerative disease (383)
Neuropsychiatric disorders (108)
Neuroscience (3243)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5121)
Now hiring (70)
Obesity (720)
Opinion (347)
Ovarian cancer (175)
Pain (226)
Pancreatic cancer (250)
Parkinson's disease (317)
Partnered (39)
Patents (545)
Patient recruitment (548)
Peanut (65)
People (67146)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23908)
Phase 2 (33578)
Phase 3 (25303)
Pipeline (6024)
Policy (358)
Postmarket research (3554)
Preclinical (10722)
Press Release (72)
Prostate cancer (272)
Psychedelics (60)
Radiopharmaceuticals (317)
Rare diseases (1006)
Real estate (7445)
Recruiting (81)
Regulatory (29333)
Reports (69)
Research institute (2742)
Resumes & cover letters (653)
Rett syndrome (30)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (275)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (117)
Tariffs (101)
The Weekly (128)
Vaccines (1191)
Venture capital (101)
Weight loss (493)
Women's health (104)
Worklife (23)
Date
Today (162)
Last 7 days (985)
Last 30 days (3037)
Last 365 days (32795)
2026 (5475)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (355)
Arkansas (15)
Asia (51687)
Australia (9083)
California (12167)
Canada (3465)
China (1228)
Colorado (514)
Connecticut (528)
Delaware (362)
Europe (118926)
Florida (1810)
Georgia (395)
Hawaii (4)
Idaho (68)
Illinois (1013)
India (80)
Indiana (574)
Iowa (24)
Japan (466)
Kansas (135)
Kentucky (47)
Louisiana (32)
Maine (84)
Maryland (1513)
Massachusetts (8917)
Michigan (380)
Minnesota (684)
Mississippi (7)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (133)
New Hampshire (88)
New Jersey (3269)
New Mexico (33)
New York (3204)
North Carolina (1679)
North Dakota (10)
Northern California (5885)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2419)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4711)
Tennessee (185)
Texas (1911)
United States (43756)
Utah (368)
Vermont (1)
Virginia (306)
Washington D.C. (88)
Washington State (1009)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 873,162 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Cuts at Merck, Disc Leave Hundreds Jobless
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
March 2, 2026
·
60 min read
·
BioSpace Editorial Staff
IPO
Generate Arrives on Nasdaq Ready To Finally Show the World AI-Powered Medicines
Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.
March 2, 2026
·
3 min read
·
Annalee Armstrong
Approvals
Ascendis Enters Achondroplasia Arena as FDA Approves First Weekly Drug
Yuviwel will compete with BioMarin’s Voxzogo. Meanwhile, BridgeBio is working to bring its own achondroplasia drug, the FGFR3 blocker infigratinib, to the market.
March 2, 2026
·
2 min read
·
Tristan Manalac
Press Releases
PVP Labs to Showcase Breakthrough Peptide Therapy Pipeline and Non-Addictive Analgesic, Taphalgin®, at LSX Investival Showcase USA in Miami
March 2, 2026
·
2 min read
Press Releases
Avenacy Announces Launch of Diphenhydramine Hydrochloride Injection, USP in the U.S. Market
March 2, 2026
·
3 min read
Press Releases
Charles River Laboratories to Present at TD Cowen and Barclays Conferences
March 2, 2026
·
1 min read
Press Releases
AOM Infusion Among the First to Earn New Immunoglobulin (Ig) Distinction Recognizing Centers of Excellence
March 2, 2026
·
3 min read
Press Releases
Rallybio Corporation and Candid Therapeutics Announce Merger Agreement
March 2, 2026
·
15 min read
Press Releases
Genetix Announces 2025 Commercial Performance Results and Outlines 2026 Strategic Priorities
March 2, 2026
·
16 min read
Press Releases
NEOK Bio Secures FDA IND Clearance for NEOK002, a Novel EGFR/MUC1 Bispecific ADC for Treatment of Solid Tumors
March 2, 2026
·
2 min read
1 of 87,317
Next
